BL
GDRX icon

Bryan Lawrence’s GoodRx Holdings GDRX Stock Holding History

Bryan Lawrence’s Portfolio GDRX Stock Details GDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-296,233
Closed -$9.68M – 11
2021
Q4 		$9.68M Buy
+296,233
New +$11.9M 4.42% 10

Other funds holding GDRX

FPM
Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
SLG
Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return
TCMX
Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $2.83B AUM 12.55% 1-Year Est. Return
RRCP
Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $3.14B AUM 46.44% 1-Year Est. Return

Bryan Lawrence's GDRX Position: Q1 2022 in Review

Bryan Lawrence sold out of GoodRx Holdings (GDRX) in Q1 2022, closing a stake of 296,233 shares — an estimated $9.68M sold.

Bryan Lawrence first reported a position in GDRX in Q4 2021 and held it in 1 quarter. The position peaked at $9.68M in Q4 2021. 167 funds tracked by Wall St. Rank hold GDRX as of Q1 2022.

  • Bryan Lawrence reported no remaining GoodRx Holdings position as of Q1 2022 after selling out during the quarter.
  • Bryan Lawrence sold 296,233 GoodRx Holdings shares in Q1 2022, an estimated $9.68M.
  • Bryan Lawrence first reported a position in GoodRx Holdings in Q4 2021 and held it in 1 quarter.
  • Bryan Lawrence's GoodRx Holdings position peaked at $9.68M in Q4 2021.
  • 167 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2022.

Based on Oakcliff Capital Partners's 13F filing for Q1 2022, filed 16 May 2022.